首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Rsc medicinal chemistry

缩写:

ISSN:N/A

e-ISSN:2632-8682

IF/分区:3.6/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1419
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ahmed G Eissa,Lauren E Powell,Julia Gee et al. Ahmed G Eissa et al.
Aromatase (CYP19A1) inhibitors are the mainstay therapeutics for the treatment of hormone dependant breast cancer, which accounts for approximately 70% of all breast cancer cases. However, increased resistance to the clinically used aromata...
Belal O Al-Najjar,Manal A Abbas,Obada A Sibai et al. Belal O Al-Najjar et al.
P2Y12 has a key role in platelet aggregation and thrombus formation via an ADP-induced platelet activation mechanism. Recently, P2Y12 antagonists have become of great interest in the clinical management of antithrombotic therapy. In light o...
Bruno M F Gonçalves,Vanessa I S Mendes,Samuel M Silvestre et al. Bruno M F Gonçalves et al.
Arjunolic acid (AA) is a pentacyclic triterpenoid with promising anticancer properties. A series of novel AA derivatives containing a pentameric A-ring with an enal moiety, combined with additional modifications at C-28, were designed and p...
Renzo Carlucci,Gabriel Di Gresia,María Gabriela Mediavilla et al. Renzo Carlucci et al.
We have previously shown that prenyl and aliphatic triazoles are interesting motifs to prepare new chemical entities for antiparasitic and antituberculosis drug development. In this opportunity a new series of prenyl-1,2,3-triazoles were pr...
Michael Kugler,Martin Hadzima,Rastislav Dzijak et al. Michael Kugler et al.
The development of highly active and selective enzyme inhibitors is one of the priorities of medicinal chemistry. Typically, various high-throughput screening methods are used to find lead compounds from a large pool of synthetic compounds,...
Rebecca L Whitehouse,Wesam S Alwan,Olga V Ilyichova et al. Rebecca L Whitehouse et al.
Fragment-based drug design relies heavily on structural information for the elaboration and optimisation of hits. The ability to identify neighbouring binding hot spots, energetically favourable interactions and conserved binding motifs in ...
Lijia Chen,Jay Chauhan,Jeremy L Yap et al. Lijia Chen et al.
The anti-apoptotic protein MCL-1, which is overexpressed in multiple cancers, is presently a focus for the development of targeted drugs in oncology. We previously discovered inhibitors of MCL-1 based on 1-sulfonylated 1,2,3,4-tetrahydroqui...
Nian Liu,Xin Wang,Qinglin Fu et al. Nian Liu et al.
Tropomyosin receptor kinases (TRKs) are associated with the proliferation and differentiation of cells, and thus their continuous activation and overexpression cause cancer. Herein, based on scaffold hopping and computer-aid drug design, 38...
Karunanidhi Gnanavelu,Vinay Kumar K S,Sumesh Eswaran et al. Karunanidhi Gnanavelu et al.
A communicable disease such as tuberculosis (TB), which takes ∼10 million lives worldwide every year, is one of the major concerns for future generations. The intake of multiple antibiotics is increasing because of the emergence of multipl...
Shiwei Su,Liqing Chen,Menglan Yang et al. Shiwei Su et al.
Toll-like receptor 4 (TLR4) is a reliable target for the development of vaccine adjuvants. To identify novel TLR4 ligands with improved immunological properties for use as adjuvants for a RBD-hFc based SARS-CoV-2 vaccine, herein, natural E....